skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Centromere/kinetochore protein genes for cancer diagnosis, prognosis and treatment selection

Patent ·
OSTI ID:1925056

The invention described in the application relates to a panel of gene expression markers for patient with a tumor. The invention thus provides methods and compositions, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to evaluate the likelihood of disease progression or response to chemotherapy or radiation therapy. Such information can be used in determining prognosis and treatment options for cancer patients.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-05CH11231; R01CA116481; R01GM066272; R01GM119011
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
11,434,535
Application Number:
15/312,138
OSTI ID:
1925056
Resource Relation:
Patent File Date: 05/18/2015
Country of Publication:
United States
Language:
English

References (10)

Modulators of Hec1 activity and methods therefor patent-application July 2013
Low density micro-array analysis in human breast cancer patent-application September 2004
Biomarkers for the prognosis and high-grade glioma clinical outcome patent-application May 2012
Nucleic acid probes for detection and/or quantitation of non-viral organisms patent July 1996
Method for identifying novel minor histocompatibility antigens patent-application August 2015
Engineered kinetochores and uses thereof patent-application October 2013
Kinetochore genes are coordinately up-regulated in human tumors as part of a FoxM1-related cell division program journal July 2014
Gene expression profiles to predict breast cancer outcomes patent-application June 2011
Oligonucleotides patent June 2003
Cancer Specific Mitotic Network patent-application August 2012